Advertisements



France says equal access to any Sanofi virus vaccine is non-negotiable

France on Thursday said equal access to any coronavirus vaccine developed by Sanofi was non-negotiable and that no country such as the United States should have priority for financial reasons. Ciara Lee reports.....»»

Category: videoSource: reutersMay 14th, 2020

Novavax jumps 10% on deal to provide over 1 billion doses of its COVID-19 vaccine globally

Novavax is working with GAVI to promote equal access to its COVID-19 vaccine globally. The company will supply 1.1 billion doses under the agreement. Kate Bingham, Chair of the Government's Vaccine Taskforce, with a plas.....»»

Category: worldSource: nytFeb 19th, 2021

Sanofi walked back a promise to give the US priority access to its coronavirus vaccine after outrage from the French government

Sean Elias/Handout via REUTERS French pharmaceutical giant scrapped a plan to give the US pri.....»»

Category: topSource: businessinsiderMay 15th, 2020

The Covid-19 Vaccine Fight Is Getting Ugly

The spat between France and drugmaker Sanofi shows when taxpayer money meets Big Pharma, the spoils aren’t always equally divided......»»

Category: topSource: washpostMay 14th, 2020

Agence France-Presse: France says would be ‘unacceptable’ for Sanofi vaccine to go to U.S. first

It would be “unacceptable” for French pharmaceutical giant Sanofi to cater first to the U.S. market if it finds a coronavirus vaccine, deputy finance minister Agnes Pannier-Runacher said Thursday......»»

Category: topSource: marketwatchMay 14th, 2020

Sanofi to speed up European COVID-19 vaccine access, Reuters says

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 13th, 2020

Sanofi to accelerate European COVID-19 vaccine access after CEO prioritizes U.S. preorders

French drugmaker Sanofi SA said on Wednesday that it is working with European regulators to speed up access to a potential coronavirus vaccine in Europe after its chief executive suggested Americans would likely get the vaccine first......»»

Category: topSource: reutersMay 13th, 2020

Sanofi CEO Talks Coronavirus Vaccine Development, Potential Treatment

France-based global drugmaker Sanofi SA (NYSE: SNY) is working on developing a coronavirus vaccine under the assumption the pandemic will resume "in some form" into 2021, CEO Paul Hudson said Wednesday in a read more.....»»

Category: blogSource: benzingaApr 8th, 2020

Tesla upgraded by Morgan Stanley on expectations it has liquidity, access to capital to manage through virus

Tesla Inc. shares were upgraded to equal weight from underperform by Morgan Stanley on Thursday, with analysts led by Adam Jonas.....»»

Category: topSource: marketwatchMar 19th, 2020

Undeterred by Sanofi"s stumble, Takeda takes similar path with dengue shot

A new vaccine for the dengue virus is taking a potentially risky road to prevent the mosquito-borne disease that infects nearly 400 million people each year......»»

Category: topSource: reutersJan 30th, 2019

Pfizer Stock Rises on Upbeat RSV Vaccine Trial Data

Pfizer Inc (NYSE: PFE) stock is up 1.7% at $27.04 at last check, following news a late-stage trial of its respiratory syncytial virus (RSV) vaccine Abrysvo generated an immune response in higher risk adults under the age of 60. read more.....»»

Category: blogSource: benzingaApr 11th, 2024

Coronavirus links: becoming endemic

A coronavirus pandemic linkfest is for now a weekly feature here on Abnormal Returns. Please stay safe and find a vaccination site... VaccinesThe Sanofi-GSK vaccine is entering Phase 3 trials. (statnews.com)There .....»»

Category: blogSource: abnormalreturnsMay 22nd, 2021

Coronavirus Update: Almost half U.S. population is partially vaccinated against COVID-19 — while Asia remains a virus hot spot

The U.S. COVID-19 vaccine drive is showing marked progress in reducing infections, hospitalizations and deaths with new cases down 32% in the last two weeks, according to a New York Times tracker, and almost 50% of Americans are partially vaccinated......»»

Category: topSource: marketwatchMay 17th, 2021

GSK, Sanofi say Covid vaccine achieved "strong rates" of antibody responses

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 17th, 2021

Sanofi and GlaxoSmithKline say their COVID-19 vaccine triggers a strong immune response, bolstering the late-comer program"s potential as a booster shot

The .....»»

Category: topSource: businessinsiderMay 17th, 2021

Delaying a 2nd dose of Pfizer"s vaccine by 9 weeks could boost antibodies to the virus, data suggests

Pfizer recommends three weeks between shots. The study compared a three-week .....»»

Category: topSource: businessinsiderMay 13th, 2021

Cuomo Unveils Vaccine-Segregated Access To Yankees/Mets Games

Cuomo Unveils Vaccine-Segregated Access To Yankees/Mets Games New York and .....»»

Category: personnelSource: nytMay 5th, 2021

Ocugen jumps 27% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of Ocugen jumped 27% on Monda.....»»

Category: topSource: businessinsiderMay 3rd, 2021

Ocugen jumps 20% after its COVID-19 vaccine shows potential effectiveness against virus variants

Studies have demonstrated Covaxin's potential effectiveness against coronavirus strains first seen in Brazil, the UK, and India. lechatnoir/Getty Images Shares of O.....»»

Category: smallbizSource: nytMay 3rd, 2021

Sanofi tells Bloomberg BARDA asking it to "go on" with vaccine candidates

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallApr 28th, 2021

: People of color face multiple barriers to vaccine access — including ‘skepticism of a system that has treated them poorly’

'The demand is there,' said Nida Al-Ramahi, a Penn Medicine administrative fellow......»»

Category: topSource: marketwatchApr 26th, 2021